IRIS
MALAPELLE, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.442
EU - Europa 1.791
AS - Asia 1.341
AF - Africa 51
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.394
IT - Italia 1.028
SG - Singapore 895
CN - Cina 315
DE - Germania 151
NL - Olanda 149
IE - Irlanda 100
FI - Finlandia 94
ES - Italia 75
GB - Regno Unito 57
IN - India 49
CA - Canada 47
CI - Costa d'Avorio 42
UA - Ucraina 26
FR - Francia 22
GR - Grecia 19
JP - Giappone 19
IR - Iran 17
SE - Svezia 17
HK - Hong Kong 13
BE - Belgio 12
VN - Vietnam 9
PK - Pakistan 6
AR - Argentina 5
MA - Marocco 5
RO - Romania 5
KR - Corea 4
PL - Polonia 4
RS - Serbia 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
NO - Norvegia 3
PT - Portogallo 3
TR - Turchia 3
AT - Austria 2
AU - Australia 2
BR - Brasile 2
CH - Svizzera 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
IL - Israele 2
IS - Islanda 2
RU - Federazione Russa 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
MX - Messico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 6.639
Salva come PNG Salva come JPEG
Città #
Singapore 736
Chandler 682
Millbury 199
Naples 180
Ashburn 172
Santa Clara 166
Lawrence 145
Amsterdam 136
Des Moines 128
Napoli 123
Boston 95
Beijing 89
Milan 87
Princeton 75
Nanjing 74
Wilmington 68
Valencia 60
Rome 47
Munich 41
Ottawa 38
Nanchang 26
Fairfield 24
Dublin 19
Redwood City 19
Boardman 17
Kronberg 17
Hebei 16
Lappeenranta 16
Helsinki 15
Jiaxing 15
Bologna 14
Falls Church 14
Florence 14
Heraklion 14
Woodbridge 14
Jacksonville 12
Dallas 11
Los Angeles 11
Shenyang 11
Arezzo 10
Krefeld 10
Pune 10
Tehran 10
Tianjin 10
Viareggio 10
Changsha 9
Shanghai 9
Turin 9
Council Bluffs 8
Dong Ket 8
Genoa 8
Guangzhou 8
Houston 8
Norwalk 8
Salerno 8
Seattle 8
Washington 8
Aversa 7
Bari 7
Ardabil 6
Edinburgh 6
Grosseto 6
Hangzhou 6
Karachi 6
London 6
Santa Maria 6
Scafati 6
Central 5
Frankfurt am Main 5
Naha 5
Toronto 5
Bagnoli Irpino 4
Belgrade 4
Brindisi 4
Catania 4
Chieti 4
Cilavegna 4
Padova 4
Palermo 4
Pomigliano d'Arco 4
San Mateo 4
Santiago de Compostela 4
Sciacca 4
Tokyo 4
Vibraye 4
Warsaw 4
Alba 3
Ann Arbor 3
Arielli 3
Augusta 3
Bad Bellingen 3
Bad Durrheim 3
Baronissi 3
Berlin 3
Brussels 3
Casalnuovo di Napoli 3
Chennai 3
Chicago 3
Ercolano 3
Fes 3
Totale 3.983
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 96
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 85
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 73
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 65
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 58
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 56
The Cause of Death of a Child in the 18th Century Solved by Bone Microbiome Typing Using Laser Microdissection and Next Generation Sequencing 55
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 53
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 52
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 51
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 51
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 49
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs 49
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 48
CBX7 is a tumor suppressor in mice and humans. 47
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 46
Endoscopic ultrsound-guided fine needle aspiration (EUS-FNA) in lymph nodal and mediastinal lesions : a multicenter experience 45
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 45
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 45
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 44
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 43
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 43
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 43
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 43
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 43
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 42
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 42
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 42
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 41
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 40
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 40
Role of Cytomorphology in the Era of Liquid Biopsy 40
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 39
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 39
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 39
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 39
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 39
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 39
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 38
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 38
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 37
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 37
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 37
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 37
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 36
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto thyroiditis. 36
EGFR mutation detection by microfluidic technology: a validation study. 36
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 36
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 36
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 35
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 35
UbcH10 overexpression is less pronounced in older colorectal cancer patients 35
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 35
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 35
Circulating tumour cells in predictive molecular pathology: Focus on drug-sensitive assays and 3D culture 35
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 35
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 35
EGFR analysis: Current evidence and future directions 34
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 34
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 34
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 34
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 33
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 33
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 33
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 33
Brca1/2 ngs somatic testing in clinical practice: a short report 33
Applications and limitations of oncogene mutation testing in clinical cytopathology. 32
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 32
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 32
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 32
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 32
A narrative review of lung cancer cytology in the times of coronavirus: What physicians should know 32
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 32
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 31
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 31
Methods for actionable gene fusion detection in lung cancer: now and in the future 31
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 30
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 30
Fine-needle aspiration findings in focal (nodular) myositis of a newborn: A case report 30
Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing 30
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 30
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 30
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 30
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 30
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 30
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) 30
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 30
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 30
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 30
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review 29
Eurocytology, module n.10: Spleen cytology 29
Cytological and molecular diagnosis of solid variant of papillary thyroid carcinoma: a case report. 29
Metastasis of Colon Cancer To the Thyroid Gland: A Case Diagnosed On Fine-needle Aspirate By A Combined Cytologic, Immunocytochemical and Molecular Approach 29
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 29
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 29
Predictive molecular pathology in the time of COVID-19 29
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 29
Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis 29
Biomarkers predictive value in early stage non-small cell lung cancer 29
Critical aspects of MSI testing in endometrial cancer: a comparison study 28
Totale 3.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020301 0 0 0 0 23 10 6 130 1 39 80 12
2020/2021406 7 4 10 2 17 93 22 58 60 57 49 27
2021/20221.162 33 15 24 16 13 23 15 101 105 118 246 453
2022/20231.795 248 87 67 125 230 200 8 202 292 162 143 31
2023/20241.466 62 225 146 64 62 98 56 171 48 77 276 181
2024/20251.302 462 554 45 70 171 0 0 0 0 0 0 0
Totale 7.127